Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong-Reference-Cited by-同舟云学术

Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong

Published:2022-03 Issue: Volume:77 Page:103904
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Peng Qiaoli,Zhou Runhong,Wang Yuewen,Zhao Meiqing,Liu Na,Li Shuang,Huang Haode,Yang Dawei,Au Ka-Kit^ORCID,Wang Hui,Man Kwan^ORCID,Yuen Kwok-Yung,Chen Zhiwei^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference49 articles.

1. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020

2. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021

3. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK;Voysey;Lancet,2021

4. Safety and efficacy of single-dose Ad26. COV2. S vaccine against Covid-19;Sadoff;N Engl J Med,2021

5. Palacios R, Batista AP, Albuquerque CSN, et al. Efficacy and safety of a COVID-19 inactivated vaccine in healthcare professionals in Brazil: the PROFISCOV study. 2021.

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in virus and immune dynamics for SARS-CoV-2 Delta and Omicron infections by age and vaccination histories;BMC Infectious Diseases;2024-06-29

2. Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines;Biosafety and Health;2024-06

3. Sero-epidemiological investigation and cross-neutralization activity against SARS-CoV-2 variants in cats and dogs, Thailand;Frontiers in Veterinary Science;2024-05-06

4. Long-term levels of protection of different types of immunity against the Omicron variant: a rapid literature review;Swiss Medical Weekly;2024-05-06

5. Clinical outcomes and risk factors for SARS-CoV-2 breakthrough cases following vaccination with BNT162b2, CoronaVac, or ChAdOx1-S: A retrospective cohort study in Malaysia;Heliyon;2024-04